 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis |
| Nagesh Kamat, Sudheer K Vuyyuru, Saurabh Kedia, Pabitra Sahu, Bhaskar Kante, Peeyush Kumar, Mukesh Kumar Ranjan, Mukesh Kumar Singh, Sambuddha Kumar, Vikas Sachdev, Govind Makharia, Vineet Ahuja |
|
Intest Res. 2022;20(2):269-273. Published online February 8, 2022 DOI: https://doi.org/10.5217/ir.2021.00064 |
|
Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis Intestinal Research. 2022;20(2):269-273  P185 Correlation of patient-reported outcome measure with clinical disease activity and faecal calprotectin in patients with ulcerative colitis Journal of Crohn's and Colitis. 2019;13(Supplement_1):S182-S183 Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome PLOS ONE. 2017;12(9):e0185131 P227 Patient experiences in ulcerative colitis: conceptual model and review of patient-reported outcome measures Journal of Crohn's and Colitis. 2023;17(Supplement_1):i381-i382 Mo1739 CORRELATION BETWEEN SERUM AND FECAL BIOMARKERS AND PATIENT REPORTED OUTCOMES IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS Gastroenterology. 2023;164(6):S-887 P111 CORRELATION OF FECAL CALPROTECTIN AND MUCOSAL BIOPSY IN IDENTIFYING SUBCLINICAL INFLAMMATION IN ULCERATIVE COLITIS PATIENTS: A PRELIMINARY STUDY Gastroenterology. 2020;158(3):S27-S28 Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial Gastroenterology. 2016;150(1):96-102 Fecal Calprotectin Evaluation in Patients with Ulcerative Colitis Digestive Diseases and Sciences. 2015;60(4):1109-1110 P111 CORRELATION OF FECAL CALPROTECTIN AND MUCOSAL BIOPSY IN IDENTIFYING SUBCLINICAL INFLAMMATION IN ULCERATIVE COLITIS PATIENTS: A PRELIMINARY STUDY Inflammatory Bowel Diseases. 2020;26(Supplement_1):S16-S17 Tu1109 Evaluation of the Relationship Between Fecal Calprotectin Concentrations and Clinical and Endoscopic Outcome Measures in a Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis Gastroenterology. 2013;144(5):S-764 |
